Home >> MARKETPLACE >> FDA clears Alinity h-series hematology system

FDA clears Alinity h-series hematology system

image_pdfCreate PDF

October 2023—Abbott has received FDA clearance for its Alinity h-series hematology system, which includes the Alinity hq, an automated hematology analyzer, and Alinity hs, an integrated slide maker and stainer. The Alinity hq leverages multiangle polarized scatter separation (MAPPS) technology, which uses light scattering to distinguish cellular features and identify various blood cells, and processes up to 119 CBC results per hour. The system can be integrated into an existing core lab operation.

Abbott, 224-667-6100

CAP TODAY
X